{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:21:18Z","timestamp":1770747678138,"version":"3.49.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,7]]},"DOI":"10.7759\/cureus.71040","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T05:00:59Z","timestamp":1728363659000},"source":"Crossref","is-referenced-by-count":2,"title":["The Role of Adjunctive Triamcinolone Acetonide in Post-traumatic Vitreoretinal Surgery: Current Insights and Future Perspectives"],"prefix":"10.7759","author":[{"given":"Anand","family":"Gandhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"Daigavane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4978973","article-title":"Timing and outcomes of vitreoretinal surgery after traumatic retinal detachment","volume":"14","author":"Orban M","year":"2016","unstructured":"Orban M, Islam YF, Haddock LJ. Timing and outcomes of vitreoretinal surgery after traumatic retinal detachment. J Ophthalmol. 2016, 14:4978973. 10.1155\/2016\/4978973","journal-title":"J Ophthalmol"},{"key":"ref2","article-title":"Macular edema","author":"Kohli P","year":"2024","unstructured":"Kohli P, Tripathy K, Patel BC. Macular edema. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK576396\/:"},{"key":"ref3","article-title":"Blunt eye trauma","author":"Mohseni M","year":"2024","unstructured":"Mohseni M, Blair K, Gurnani B, Bragg BN. Blunt eye trauma. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470379\/:"},{"key":"ref4","article-title":"Retinal detachment","author":"Blair K","year":"2024","unstructured":"Blair K, Czyz CN. Retinal detachment. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551502\/:"},{"key":"ref5","article-title":"Vitrectomy","author":"Omari A","year":"2024","unstructured":"Omari A, Mahmoud TH. Vitrectomy. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551668\/:"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.65893","article-title":"Advancements in therapeutic approaches for proliferative vitreoretinopathy: a comprehensive review","volume":"16","author":"Dhawale KK","year":"2024","unstructured":"Dhawale KK, Tidake P. Advancements in therapeutic approaches for proliferative vitreoretinopathy: a comprehensive review. Cureus. 2024, 16:e65893. 10.7759\/cureus.65893","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s3434","article-title":"Use of triamcinolone during vitrectomy surgery to visualize membranes and vitreous","volume":"2","author":"Couch SM","year":"2008","unstructured":"Couch SM, Bakri SJ. Use of triamcinolone during vitrectomy surgery to visualize membranes and vitreous. Clin Ophthalmol. 2008, 2:891-6. 10.2147\/opth.s3434","journal-title":"Clin Ophthalmol"},{"key":"ref8","article-title":"Triamcinolone","author":"Sidhu G","year":"2024","unstructured":"Sidhu G, Preuss CV. Triamcinolone. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK544309\/:"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.346460","article-title":"Functions and mechanisms of cytosolic phospholipase A(2) in central nervous system trauma","volume":"18","author":"Zhang HJ","year":"2023","unstructured":"Zhang HJ, Chen YT, Hu XL, Cai WT, Wang XY, Ni WF, Zhou KL. Functions and mechanisms of cytosolic phospholipase A(2) in central nervous system trauma. Neural Regen Res. 2023, 18:258-66. 10.4103\/1673-5374.346460","journal-title":"Neural Regen Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10225300","article-title":"Treatment of macular edema in vascular retinal diseases: a 2021 update","volume":"10","author":"Grzybowski A","year":"2021","unstructured":"Grzybowski A, Markeviciute A, Zemaitiene R. Treatment of macular edema in vascular retinal diseases: a 2021 update. J Clin Med. 2021, 10:5300. 10.3390\/jcm10225300","journal-title":"J Clin Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1625_20","article-title":"Pars plana vitrectomy in uveitis in the era of microincision vitreous surgery","volume":"68","author":"Bansal R","year":"2020","unstructured":"Bansal R, Dogra M, Chawla R, Kumar A. Pars plana vitrectomy in uveitis in the era of microincision vitreous surgery. Indian J Ophthalmol. 2020, 68:1844-51. 10.4103\/ijo.IJO_1625_20","journal-title":"Indian J Ophthalmol"},{"key":"ref12","article-title":"Retinal traction detachment","author":"Mishra C","year":"2024","unstructured":"Mishra C, Tripathy K. Retinal traction detachment. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK558952\/:"},{"key":"ref13","article-title":"Retinal detachment","volume":"14","author":"Steel D","year":"2014","unstructured":"Steel D. Retinal detachment. BMJ Clin Evid. 2014, 14:0710.","journal-title":"BMJ Clin Evid"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.embor.7401108","article-title":"The cutting edge. A synergy of modern surgical techniques and science improves patient survival and recovery","volume":"8","author":"Hunter P","year":"2007","unstructured":"Hunter P. The cutting edge. A synergy of modern surgical techniques and science improves patient survival and recovery. EMBO Rep. 2007, 8:999-1002. 10.1038\/sj.embor.7401108","journal-title":"EMBO Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12165287","article-title":"Proliferative vitreoretinopathy: a reappraisal","volume":"12","author":"Carpineto P","year":"2023","unstructured":"Carpineto P, Licata AM, Ciancaglini M. Proliferative vitreoretinopathy: a reappraisal. J Clin Med. 2023, 12:5287. 10.3390\/jcm12165287","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i15.3546","article-title":"Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: a retrospective cohort study","volume":"9","author":"Xiong B","year":"2021","unstructured":"Xiong B, He LM, Qin YY, et al.. Effectiveness of adjunctive corticosteroid therapy in patients with severe COVID-19: a retrospective cohort study. World J Clin Cases. 2021, 9:3546-58. 10.12998\/wjcc.v9.i15.3546","journal-title":"World J Clin Cases"},{"key":"ref17","article-title":"Eye trauma imaging","author":"Wang D","year":"2024","unstructured":"Wang D, Rizzuti A. Eye trauma imaging. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK572102\/:"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s4477","article-title":"Intravitreal triamcinolone for intraocular inflammation and associated macular edema","volume":"3","author":"Couch SM","year":"2009","unstructured":"Couch SM, Bakri SJ. Intravitreal triamcinolone for intraocular inflammation and associated macular edema. Clin Ophthalmol. 2009, 3:41-7. 10.2147\/opth.s4477","journal-title":"Clin Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/IIO.0000000000000258","article-title":"Proliferative vitreoretinopathy: a review","volume":"59","author":"Idrees S","year":"2019","unstructured":"Idrees S, Sridhar J, Kuriyan AE. Proliferative vitreoretinopathy: a review. Int Ophthalmol Clin. 2019, 59:221-40. 10.1097\/IIO.0000000000000258","journal-title":"Int Ophthalmol Clin"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_928_22","article-title":"Vitreous hemorrhage - causes, diagnosis, and management","volume":"71","author":"Shaikh N","year":"2023","unstructured":"Shaikh N, Srishti R, Khanum A, et al.. Vitreous hemorrhage - causes, diagnosis, and management. Indian J Ophthalmol. 2023, 71:28-38. 10.4103\/ijo.IJO_928_22","journal-title":"Indian J Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2021.01.014","article-title":"The choroidal rupture: current concepts and insights","volume":"66","author":"Lupidi M","year":"2021","unstructured":"Lupidi M, Muzi A, Castellucci G, Kalra G, Piccolino FC, Chhablani J, Cagini C. The choroidal rupture: current concepts and insights. Surv Ophthalmol. 2021, 66:761-70. 10.1016\/j.survophthal.2021.01.014","journal-title":"Surv Ophthalmol"},{"key":"ref22","article-title":"Macular hole","author":"Majumdar S","year":"2024","unstructured":"Majumdar S, Tripathy K. Macular hole. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559200\/:"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6701319","article-title":"Postoperative intraocular pressure spikes: the need to treat","volume":"18","author":"Tranos P","year":"2004","unstructured":"Tranos P, Bhar G, Little B. Postoperative intraocular pressure spikes: the need to treat. Eye (Lond). 2004, 18:673-9. 10.1038\/sj.eye.6701319","journal-title":"Eye (Lond)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jfb3030642","article-title":"Control of scar tissue formation in the cornea: strategies in clinical and corneal tissue engineering","volume":"3","author":"Wilson SL","year":"2012","unstructured":"Wilson SL, El Haj AJ, Yang Y. Control of scar tissue formation in the cornea: strategies in clinical and corneal tissue engineering. J Funct Biomater. 2012, 3:642-87. 10.3390\/jfb3030642","journal-title":"J Funct Biomater"},{"key":"ref25","article-title":"Traumatic cataract","author":"Okoye GS","year":"2024","unstructured":"Okoye GS, Gurnani B. Traumatic cataract. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK594251\/:"},{"key":"ref26","article-title":"Rehabilitation: essential along the continuum of care","author":"Mills T","year":"2017","unstructured":"Mills T, Marks E, Reynolds T, Cieza A. Rehabilitation: essential along the continuum of care. Disease Control Priorities: Improving Health and Reducing Poverty. The International Bank for Reconstruction and Development\/The World Bank, Washington (DC); 2017."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11071901","article-title":"The evolution of triamcinolone acetonide therapeutic use in retinal diseases: from off-label intravitreal injection to advanced nano-drug delivery systems","volume":"11","author":"Aceves-Franco LA","year":"2023","unstructured":"Aceves-Franco LA, Sanchez-Aguilar OE, Barragan-Arias AR, Ponce-Gallegos MA, Navarro-Partida J, Santos A. The evolution of triamcinolone acetonide therapeutic use in retinal diseases: from off-label intravitreal injection to advanced nano-drug delivery systems. Biomedicines. 2023, 11:1901. 10.3390\/biomedicines11071901","journal-title":"Biomedicines"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15896","article-title":"Postoperative systemic inflammatory dysregulation and corticosteroids: a narrative review","volume":"78","author":"Bain CR","year":"2023","unstructured":"Bain CR, Myles PS, Corcoran T, Dieleman JM. Postoperative systemic inflammatory dysregulation and corticosteroids: a narrative review. Anaesthesia. 2023, 78:356-70. 10.1111\/anae.15896","journal-title":"Anaesthesia"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11216428","article-title":"Advances in vitreoretinal surgery","volume":"11","author":"Ribeiro L","year":"2022","unstructured":"Ribeiro L, Oliveira J, Kuroiwa D, et al.. Advances in vitreoretinal surgery. J Clin Med. 2022, 11:6428. 10.3390\/jcm11216428","journal-title":"J Clin Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3205\/000309","article-title":"Internal limiting membrane peeling in macular hole surgery","volume":"20","author":"Pradhan D","year":"2022","unstructured":"Pradhan D, Agarwal L, Joshi I, Kushwaha A, Aditya K, Kumari A. Internal limiting membrane peeling in macular hole surgery. Ger Med Sci. 2022, 20:10.3205\/000309","journal-title":"Ger Med Sci"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S279611","article-title":"Outcomes of epiretinal membrane removal utilizing triamcinolone acetonide visualization and internal limiting membrane forceps","volume":"14","author":"Asahi MG","year":"2020","unstructured":"Asahi MG, Wallsh JO, Gallemore RP. Outcomes of epiretinal membrane removal utilizing triamcinolone acetonide visualization and internal limiting membrane forceps. Clin Ophthalmol. 2020, 14:3913-21. 10.2147\/OPTH.S279611","journal-title":"Clin Ophthalmol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.4103\/sjopt.sjopt_147_21","article-title":"New insights into cataract surgery in patients with uveitis: a detailed review of the current literature","volume":"36","author":"Al-Essa RS","year":"2022","unstructured":"Al-Essa RS, Alfawaz AM. New insights into cataract surgery in patients with uveitis: a detailed review of the current literature. Saudi J Ophthalmol. 2022, 36:133-41. 10.4103\/sjopt.sjopt_147_21","journal-title":"Saudi J Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrs.2016.06.006","article-title":"Cataract surgery and nonsteroidal antiinflammatory drugs","volume":"42","author":"Hoffman RS","year":"2016","unstructured":"Hoffman RS, Braga-Mele R, Donaldson K, et al.. Cataract surgery and nonsteroidal antiinflammatory drugs. J Cataract Refract Surg. 2016, 42:1368-79. 10.1016\/j.jcrs.2016.06.006","journal-title":"J Cataract Refract Surg"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-018-0135-x","article-title":"Retina and glaucoma: surgical complications","volume":"4","author":"Sahoo NK","year":"2018","unstructured":"Sahoo NK, Balijepalli P, Singh SR, Jhingan M, Senthil S, Chhablani J. Retina and glaucoma: surgical complications. Int J Retina Vitreous. 2018, 4:29. 10.1186\/s40942-018-0135-x","journal-title":"Int J Retina Vitreous"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11030657","article-title":"Novel therapies for the prevention of fibrosis in glaucoma filtration surgery","volume":"11","author":"Shao CG","year":"2023","unstructured":"Shao CG, Sinha NR, Mohan RR, Webel AD. Novel therapies for the prevention of fibrosis in glaucoma filtration surgery. Biomedicines. 2023, 11:657. 10.3390\/biomedicines11030657","journal-title":"Biomedicines"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2016.12.010","article-title":"Management of high-risk corneal transplantation","volume":"62","author":"Di Zazzo A","year":"2017","unstructured":"Di Zazzo A, Kheirkhah A, Abud TB, Goyal S, Dana R. Management of high-risk corneal transplantation. Surv Ophthalmol. 2017, 62:816-27. 10.1016\/j.survophthal.2016.12.010","journal-title":"Surv Ophthalmol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3310\/GNBJ1387","article-title":"A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma - the ASCOT study","volume":"27","author":"Charteris DG","year":"2023","unstructured":"Charteris DG, Cro S, Casswell E, et al.. A randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery for open globe trauma - the ASCOT study. Health Technol Assess. 2023, 27:1-50. 10.3310\/GNBJ1387","journal-title":"Health Technol Assess"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1136\/bjo-2022-322787","article-title":"Randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery following open globe trauma: the ASCOT study","volume":"108","author":"Casswell EJ","year":"2024","unstructured":"Casswell EJ, Cro S, Cornelius VR, et al.. Randomised controlled trial of adjunctive triamcinolone acetonide in eyes undergoing vitreoretinal surgery following open globe trauma: the ASCOT study. Br J Ophthalmol. 2024, 108:440-8. 10.1136\/bjo-2022-322787","journal-title":"Br J Ophthalmol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-016-1464-4","article-title":"A phase III, multi-centre, double-masked randomised controlled trial of adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): statistical analysis plan","volume":"17","author":"Lo JW","year":"2016","unstructured":"Lo JW, Bunce C, Charteris D, Banerjee P, Phillips R, Cornelius VR. A phase III, multi-centre, double-masked randomised controlled trial of adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): statistical analysis plan. Trials. 2016, 17:383. 10.1186\/s13063-016-1464-4","journal-title":"Trials"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-016-1445-7","article-title":"Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trial","volume":"17","author":"Banerjee PJ","year":"2016","unstructured":"Banerjee PJ, Cornelius VR, Phillips R, et al.. Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trial. Trials. 2016, 17:339. 10.1186\/s13063-016-1445-7","journal-title":"Trials"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2009.233","article-title":"A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6","volume":"127","author":"Scott IU","year":"2009","unstructured":"Scott IU, Ip MS, VanVeldhuisen PC, et al.. A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with standard care to treat vision loss associated with macular edema secondary to branch retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 6. Arch Ophthalmol. 2009, 127:1115-28. 10.1001\/archophthalmol.2009.233","journal-title":"Arch Ophthalmol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-021-00261-3","article-title":"Intravitreal corticosteroids for diabetic macular edema: a network meta-analysis of randomized controlled trials","volume":"8","author":"Gao L","year":"2021","unstructured":"Gao L, Zhao X, Jiao L, Tang L. Intravitreal corticosteroids for diabetic macular edema: a network meta-analysis of randomized controlled trials. Eye Vis (Lond). 2021, 8:35. 10.1186\/s40662-021-00261-3","journal-title":"Eye Vis (Lond)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2018.08.001","article-title":"Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review","volume":"11","author":"Fogel DB","year":"2018","unstructured":"Fogel DB. Factors associated with clinical trials that fail and opportunities for improving the likelihood of success: a review. Contemp Clin Trials Commun. 2018, 11:156-64. 10.1016\/j.conctc.2018.08.001","journal-title":"Contemp Clin Trials Commun"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2147\/opth.s4033","article-title":"Cystoid macular edema","volume":"2","author":"Rotsos TG","year":"2008","unstructured":"Rotsos TG, Moschos MM. Cystoid macular edema. Clin Ophthalmol. 2008, 2:919-30. 10.2147\/opth.s4033","journal-title":"Clin Ophthalmol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2016.09.003","article-title":"Steroid-induced ocular hypertension\/glaucoma: focus on pharmacogenomics and implications for precision medicine","volume":"56","author":"Fini ME","year":"2017","unstructured":"Fini ME, Schwartz SG, Gao X, et al.. Steroid-induced ocular hypertension\/glaucoma: focus on pharmacogenomics and implications for precision medicine. Prog Retin Eye Res. 2017, 56:58-83. 10.1016\/j.preteyeres.2016.09.003","journal-title":"Prog Retin Eye Res"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.11.050","article-title":"Cataract formation and other complications of intravitreal triamcinolone for macular edema","volume":"141","author":"Thompson JT","year":"2006","unstructured":"Thompson JT. Cataract formation and other complications of intravitreal triamcinolone for macular edema. Am J Ophthalmol. 2006, 141:629-37. 10.1016\/j.ajo.2005.11.050","journal-title":"Am J Ophthalmol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjo.2015.03.004","article-title":"Immunosuppressive therapy for eye diseases: effectiveness, safety, side effects and their prevention","volume":"5","author":"Hornbeak DM","year":"2015","unstructured":"Hornbeak DM, Thorne JE. Immunosuppressive therapy for eye diseases: effectiveness, safety, side effects and their prevention. Taiwan J Ophthalmol. 2015, 5:156-63. 10.1016\/j.tjo.2015.03.004","journal-title":"Taiwan J Ophthalmol"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2017.07.024","article-title":"Fabrication, optimization and characterization of triamcinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis: application of Box Behnken design, in vitro and ex vivo studies","volume":"41","author":"Pradhan M","year":"2017","unstructured":"Pradhan M, Singh D, Singh MR. Fabrication, optimization and characterization of triamcinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis: application of Box Behnken design, in vitro and ex vivo studies. J Drug Deliv Sci Technol. 2017, 41:325-33. 10.1016\/j.jddst.2017.07.024","journal-title":"J Drug Deliv Sci Technol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2023.114950","article-title":"Solid implantable devices for sustained drug delivery","volume":"199","author":"Magill E","year":"2023","unstructured":"Magill E, Demartis S, Gavini E, et al.. Solid implantable devices for sustained drug delivery. Adv Drug Deliv Rev. 2023, 199:114950. 10.1016\/j.addr.2023.114950","journal-title":"Adv Drug Deliv Rev"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/ph16081140","article-title":"Intravitreal anti-vascular endothelial growth factor therapies for retinal disorders","volume":"16","author":"Hang A","year":"2023","unstructured":"Hang A, Feldman S, Amin AP, Ochoa JA, Park SS. Intravitreal anti-vascular endothelial growth factor therapies for retinal disorders. Pharmaceuticals (Basel). 2023, 16:1140. 10.3390\/ph16081140","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2017.02.036","article-title":"Personalized medicine: genetic risk prediction of drug response","volume":"175","author":"Zhang G","year":"2017","unstructured":"Zhang G, Nebert DW. Personalized medicine: genetic risk prediction of drug response. Pharmacol Ther. 2017, 175:75-90. 10.1016\/j.pharmthera.2017.02.036","journal-title":"Pharmacol Ther"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1177\/15330338231178403","article-title":"Recent advancements, limitations, and future perspectives of the use of personalized medicine in treatment of colon cancer","volume":"22","author":"Dey A","year":"2023","unstructured":"Dey A, Mitra A, Pathak S, et al.. Recent advancements, limitations, and future perspectives of the use of personalized medicine in treatment of colon cancer. Technol Cancer Res Treat. 2023, 22:10.1177\/15330338231178403","journal-title":"Technol Cancer Res Treat"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26195905","article-title":"Controlled drug delivery systems: current status and future directions","volume":"26","author":"Adepu S","year":"2021","unstructured":"Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021, 26:5905. 10.3390\/molecules26195905","journal-title":"Molecules"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.2006.2.2.193","article-title":"The management of glaucoma and intraocular hypertension: current approaches and recent advances","volume":"2","author":"Noecker RJ","year":"2006","unstructured":"Noecker RJ. The management of glaucoma and intraocular hypertension: current approaches and recent advances. Ther Clin Risk Manag. 2006, 2:193-206. 10.2147\/tcrm.2006.2.2.193","journal-title":"Ther Clin Risk Manag"},{"key":"ref55","article-title":"Combination therapies in ophthalmology: implications for intravitreal delivery","volume":"6","author":"Peyman GA","year":"2011","unstructured":"Peyman GA, Hosseini K. Combination therapies in ophthalmology: implications for intravitreal delivery. J Ophthalmic Vis Res. 2011, 6:36-46.","journal-title":"J Ophthalmic Vis Res"},{"key":"ref56","article-title":"Minimally invasive vitreoretinal surgery","volume":"6","author":"Arevalo JF","year":"2011","unstructured":"Arevalo JF, Berrocal MH, Arias JD, Banaee T. Minimally invasive vitreoretinal surgery. J Ophthalmic Vis Res. 2011, 6:136-44.","journal-title":"J Ophthalmic Vis Res"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612976","article-title":"Biodegradable polymer-based drug-delivery systems for ocular diseases","volume":"24","author":"Tsung TH","year":"2023","unstructured":"Tsung TH, Tsai YC, Lee HP, Chen YH, Lu DW. Biodegradable polymer-based drug-delivery systems for ocular diseases. Int J Mol Sci. 2023, 24:12976. 10.3390\/ijms241612976","journal-title":"Int J Mol Sci"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_3117_20","article-title":"Gene therapy in retinal diseases: a review","volume":"69","author":"Dhurandhar D","year":"2021","unstructured":"Dhurandhar D, Sahoo NK, Mariappan I, Narayanan R. Gene therapy in retinal diseases: a review. Indian J Ophthalmol. 2021, 69:2257-65. 10.4103\/ijo.IJO_3117_20","journal-title":"Indian J Ophthalmol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0000000000002720","article-title":"Robot-assisted vitreoretinal surgery improves surgical accuracy compared with manual surgery: a randomized trial in a simulated setting","volume":"40","author":"Forslund Jacobsen M","year":"2020","unstructured":"Forslund Jacobsen M, Konge L, Alberti M, la Cour M, Park YS, Thomsen AS. Robot-assisted vitreoretinal surgery improves surgical accuracy compared with manual surgery: a randomized trial in a simulated setting. Retina. 2020, 40:2091-8. 10.1097\/IAE.0000000000002720","journal-title":"Retina"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.4917","article-title":"Artificial intelligence and surgical decision-making","volume":"155","author":"Loftus TJ","year":"2020","unstructured":"Loftus TJ, Tighe PJ, Filiberto AC, et al.. Artificial intelligence and surgical decision-making. JAMA Surg. 2020, 155:148-58. 10.1001\/jamasurg.2019.4917","journal-title":"JAMA Surg"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2007.09.016","article-title":"Perioperative visual loss after nonocular surgeries","volume":"145","author":"Newman NJ","year":"2008","unstructured":"Newman NJ. Perioperative visual loss after nonocular surgeries. Am J Ophthalmol. 2008, 145:604-10. 10.1016\/j.ajo.2007.09.016","journal-title":"Am J Ophthalmol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2016.00071","article-title":"The efficacy of triamcinolone acetonide in keloid treatment: a systematic review and meta-analysis","volume":"3","author":"Wong TS","year":"2016","unstructured":"Wong TS, Li JZ, Chen S, Chan JY, Gao W. The efficacy of triamcinolone acetonide in keloid treatment: a systematic review and meta-analysis. Front Med (Lausanne). 2016, 3:10.3389\/fmed.2016.00071","journal-title":"Front Med (Lausanne)"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1200\/GO.22.00424","article-title":"Barriers and facilitators to implementing cost-effective evidence-based childhood cancer treatment in a resource-limited setting in Egypt: a qualitative interview study","volume":"9","author":"Soliman R","year":"2023","unstructured":"Soliman R, Heneghan C, Boylan AM, Oke J, Eweida W, Elhaddad A. Barriers and facilitators to implementing cost-effective evidence-based childhood cancer treatment in a resource-limited setting in Egypt: a qualitative interview study. JCO Glob Oncol. 2023, 9:e2200424. 10.1200\/GO.22.00424","journal-title":"JCO Glob Oncol"},{"key":"ref64","article-title":"Costs, effectiveness, and cost-effectiveness of selected surgical procedures and platforms","author":"Prinja S","year":"2015","unstructured":"Prinja S, Nandi A, Horton S, et al.. Costs, effectiveness, and cost-effectiveness of selected surgical procedures and platforms. Essential Surgery: Disease Control Priorities. The International Bank for Reconstruction and Development\/The World Bank, Washington (DC); 2015."},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-023-06264-1","article-title":"Proliferative vitreoretinopathy: an update on the current and emerging treatment options","volume":"262","author":"Ferro Desideri L","year":"2024","unstructured":"Ferro Desideri L, Artemiev D, Zandi S, Zinkernagel MS, Anguita R. Proliferative vitreoretinopathy: an update on the current and emerging treatment options. Graefes Arch Clin Exp Ophthalmol. 2024, 262:679-87. 10.1007\/s00417-023-06264-1","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.18502\/jovr.v16i3.9449","article-title":"Outcomes following pars plana vitrectomy for severe ocular trauma","volume":"16","author":"Bober NK","year":"2021","unstructured":"Bober NK, Kumaran N, Williamson TH. Outcomes following pars plana vitrectomy for severe ocular trauma. J Ophthalmic Vis Res. 2021, 16:408-14. 10.18502\/jovr.v16i3.9449","journal-title":"J Ophthalmic Vis Res"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2023.101232","article-title":"IOP and glaucoma damage: The essential role of optic nerve head and retinal mechanosensors","volume":"99","author":"Pitha I","year":"2024","unstructured":"Pitha I, Du L, Nguyen TD, Quigley H. IOP and glaucoma damage: The essential role of optic nerve head and retinal mechanosensors. Prog Retin Eye Res. 2024, 99:101232. 10.1016\/j.preteyeres.2023.101232","journal-title":"Prog Retin Eye Res"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2018.01.017","article-title":"Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients","volume":"22","author":"Rice ML","year":"2018","unstructured":"Rice ML, Wong B, Horn PS, Yang MB. Cataract development associated with long-term glucocorticoid therapy in Duchenne muscular dystrophy patients. J AAPOS. 2018, 22:192-6. 10.1016\/j.jaapos.2018.01.017","journal-title":"J AAPOS"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158182","article-title":"Retinal toxicity induced by chemical agents","volume":"23","author":"Souza Monteiro de Ara\u00fajo D","year":"2022","unstructured":"Souza Monteiro de Ara\u00fajo D, Brito R, Pereira-Figueiredo D, et al.. Retinal toxicity induced by chemical agents. Int J Mol Sci. 2022, 23:8182. 10.3390\/ijms23158182","journal-title":"Int J Mol Sci"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S265691","article-title":"Effects of repeated intravitreal injections of dexamethasone implants on intraocular pressure: a 4-year study","volume":"14","author":"Pacella E","year":"2020","unstructured":"Pacella E, Loffredo L, Malvasi M, Trovato Battagliola E, Messineo D, Pacella F, Arrico L. Effects of repeated intravitreal injections of dexamethasone implants on intraocular pressure: a 4-year study. Clin Ophthalmol. 2020, 14:3611-7. 10.2147\/OPTH.S265691","journal-title":"Clin Ophthalmol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00284","article-title":"Diabetes mellitus secondary to Cushing\u2019s disease","volume":"9","author":"Barbot M","year":"2018","unstructured":"Barbot M, Ceccato F, Scaroni C. Diabetes mellitus secondary to Cushing\u2019s disease. Front Endocrinol (Lausanne). 2018, 9:10.3389\/fendo.2018.00284","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9051556","article-title":"Preoperative, intraoperative and postoperative corticosteroid use as an adjunctive treatment for rhegmatogenous retinal detachment","volume":"9","author":"Bonfiglio V","year":"2020","unstructured":"Bonfiglio V, Reibaldi M, Macchi I, et al.. Preoperative, intraoperative and postoperative corticosteroid use as an adjunctive treatment for rhegmatogenous retinal detachment. J Clin Med. 2020, 9:1556. 10.3390\/jcm9051556","journal-title":"J Clin Med"},{"key":"ref73","article-title":"Endophthalmitis","author":"Simakurthy S","year":"2024","unstructured":"Simakurthy S, Tripathy K. Endophthalmitis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK559079\/:"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12040514","article-title":"Adherence to therapy in glaucoma treatment\u2014a review","volume":"12","author":"Zaharia AC","year":"2022","unstructured":"Zaharia AC, Dumitrescu OM, Radu M, Rogoz RE. Adherence to therapy in glaucoma treatment\u2014a review. J Pers Med. 2022, 12:514. 10.3390\/jpm12040514","journal-title":"J Pers Med"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00670-0","article-title":"Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems","volume":"22","author":"Baryakova TH","year":"2023","unstructured":"Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov. 2023, 22:387-409. 10.1038\/s41573-023-00670-0","journal-title":"Nat Rev Drug Discov"},{"key":"ref76","article-title":"Novelties in medical treatment of glaucoma","volume":"59","author":"Cornel \u015e","year":"2015","unstructured":"Cornel \u015e, Mihaela TC, Adriana ID, Mehdi B, Algerino DS. Novelties in medical treatment of glaucoma. Rom J Ophthalmol. 2015, 59:78-87.","journal-title":"Rom J Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/307359-the-role-of-adjunctive-triamcinolone-acetonide-in-post-traumatic-vitreoretinal-surgery-current-insights-and-future-perspectives","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T05:01:03Z","timestamp":1728363663000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/307359-the-role-of-adjunctive-triamcinolone-acetonide-in-post-traumatic-vitreoretinal-surgery-current-insights-and-future-perspectives"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,7]]},"references-count":76,"URL":"https:\/\/doi.org\/10.7759\/cureus.71040","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,7]]}}}